Information Provided By: 
Fly News Breaks for August 28, 2015
SPLK
Aug 28, 2015 | 07:27 EDT
Canaccord noted Splunk reported revenue upside in its Q2 results and expects its free cash flow to improve with sales growth. The firm said Q2 results were solid, which bodes well for the future. Canaccord, which expects Splunk to outperform the market this year and for several years to come, reiterated its Buy rating and $83 price target on the shares.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
